Mindset Pharma Inc.

Mindset Pharma Inc.

Mindset Pharma Inc.

Mindset Pharma is a Toronto-based drug discovery business focused on creating novel and patentable psychedelic compounds for the treatment of neurological and psychiatric disorders. Founded in 2019 by domain experts in drug development, medicinal chemistry and capital markets, Mindset is assembling a proprietary library of transformative psychedelic intellectual property designed to address chronic neuropsychiatric disorders efficiently and safely. Classic psychedelics will likely be approved for medical use in the near future, however, they are not optimized as pharmaceuticals and cannot be patented as they are in the public domain .Mindset is applying innovative medicinal chemistry to create a pipeline of optimized psychedelic medications with improved efficacy and reduced toxicity. Mindset has developed a patent-pending chemical synthesis process to address a pressing need for scalable, pharmaceutical grade, low-cost psilocybin

Address

217 Queen Street West Suite 401 Toronto, ON M5V 0R2 Canada

Phone

1 +416-479-4094

Website

https://www.mindsetpharma.com

Industry

Biotech/Healthcare

Listings

CNSX-MSET, OTCQB-MSSTF, FSE-9DF

Key Executives

James Lanthier, CEO

 

Leadership Profile

James Lanthier, CEO &- Mindset Pharma Inc.

A seasoned technology executive with strong expertise in corporate finance, public markets and M&A. Most recently, Mr. Lanthier was a co-founder and CEO of Future Fertility, an innovative early stage developer of AI applications for human infertility. As a C-Suite executive, Mr. Lanthier has assisted in the growth and successful exit of numerous technology-enabled businesses through the public markets, including Mood Media, the world’s largest in-store media provider, and Fun Technologies, a pioneer in online casual games.

News and Media

Need More Info From The Company?